WallStSmart
RPTX

Repare Therapeutics Inc

NASDAQ: RPTX · HEALTHCARE · BIOTECHNOLOGY

$2.65
+0.00% today

Updated 2026-01-28

Market cap
$114.24M
P/E ratio
—
P/S ratio
9.62x
EPS (TTM)
$-1.70
Dividend yield
—
52W range
$1 – $3
Volume
1.4M
OverviewPrice TargetsFinancialsValuationInsidersEarnings

Repare Therapeutics Inc (RPTX) Financial statements

SEC filings — annual and quarterly data.

Income statementBalance sheetCash flowProfitability

Income statement — annual

Item20172018201920202021202220232024
Revenue$0.00$0.00$0.00$135000.00$7.60M$131.83M$51.13M$53.48M
Revenue growth (YoY)————+5529.6%+1634.6%-61.2%+4.6%
Cost of revenue$102000.00$407000.00$968000.00$38.77M$87.85M$116.72M$13.24M$13.38M
Gross profit$-102000.00$-407000.00$-968000.00$-38.64M$-80.25M$15.11M$37.89M$40.10M
Gross margin———-28622.2%-1056.0%11.5%74.1%75.0%
R&D$4.40M$9.91M$19.89M$41.00M$91.17M$120.50M$133.59M$116.87M
SG&A$1.77M$2.91M$5.38M$14.35M$26.21M$32.56M$33.76M$29.68M
Operating income$-6.17M$-12.82M$-25.81M$-54.30M$-108.66M$-19.80M$-116.22M$-93.52M
Operating margin———-40223.7%-1429.7%-15.0%-227.3%-174.9%
EBITDA$-7.53M$-13.51M$-25.49M$-53.41M$-107.19M$-17.82M$-114.27M$-90.22M
EBITDA margin———-39559.3%-1410.4%-13.5%-223.5%-168.7%
EBIT$-7.63M$-13.92M$-26.45M$-54.30M$-108.66M$-19.80M$-116.22M$-92.14M
Interest expense$0.00$0.00$68000.00$207000.00$1.40M$8.18M——
Income tax————————
Effective tax rate0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%
Net income$-7.80M$-14.28M$-27.22M$-53.42M$-106.91M$-29.05M$-93.80M$-84.69M
Net income growth (YoY)—-83.2%-90.5%-96.3%-100.1%+72.8%-222.9%+9.7%
Profit margin———-39568.1%-1406.7%-22.0%-183.4%-158.4%